126 related articles for article (PubMed ID: 32535247)
1. MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review.
Smith SC; Qdaisat TZS; Althof PA; Dave BJ; Sanmann JN
Leuk Res; 2020 Aug; 95():106387. PubMed ID: 32535247
[TBL] [Abstract][Full Text] [Related]
2. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
3. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
[TBL] [Abstract][Full Text] [Related]
4. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
[TBL] [Abstract][Full Text] [Related]
5. A Rare Case of ETV6/MECOM Rearrangement in Therapy-Related Acute Myeloid Leukemia with t(3;12) and Monosomy 7.
Kim YJ; Yang JJ; Han Y; Kim S; Yang HS; Yoon HJ; Lee JH; Lee WI; Park TS
Clin Lab; 2017 Feb; 63(2):415-418. PubMed ID: 28182364
[No Abstract] [Full Text] [Related]
6. Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
Gao J; Gurbuxani S; Zak T; Kocherginsky M; Ji P; Wehbe F; Chen Q; Chen YH; Lu X; Jennings L; Frankfurt O; Altman J; Sukhanova M
Genes Chromosomes Cancer; 2022 Feb; 61(2):71-80. PubMed ID: 34668265
[TBL] [Abstract][Full Text] [Related]
7. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.
Tang Z; Tang G; Hu S; Patel KP; Yin CC; Wang W; Lin P; Toruner GA; Ok CY; Gu J; Lu X; Khoury JD; Medeiros LJ
Cancer Genet; 2019 Apr; 233-234():21-31. PubMed ID: 31109591
[TBL] [Abstract][Full Text] [Related]
9. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
10. Molecular approaches identify a cryptic MECOM rearrangement in a child with a rapidly progressive myeloid neoplasm.
Capela de Matos RR; Othman MAK; Ferreira GM; Costa ES; Melo JB; Carreira IM; de Souza MT; Lopes BA; Emerenciano M; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Cancer Genet; 2018 Feb; 221():25-30. PubMed ID: 29405993
[TBL] [Abstract][Full Text] [Related]
11. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
[TBL] [Abstract][Full Text] [Related]
12. H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia.
Han Q; Lu J; Wang J; Ye J; Jiang X; Chen H; Liu C; Chen L; Lin T; Chen S; Sun M; Gao F
Cancer Genet; 2018 Apr; 222-223():9-12. PubMed ID: 29666008
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Genomic Profiles of Korean Patients with
Lee J; Kim SM; Kim S; Yun J; Jeong D; Lee YE; Roh EY; Lee DS
Ann Lab Med; 2022 Sep; 42(5):590-596. PubMed ID: 35470277
[TBL] [Abstract][Full Text] [Related]
14. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
Lennon PA; Abruzzo LV; Medeiros LJ; Cromwell C; Zhang X; Yin CC; Kornblau SM; Konopieva M; Lin P
Cancer Genet Cytogenet; 2007 Aug; 177(1):37-42. PubMed ID: 17693189
[TBL] [Abstract][Full Text] [Related]
15. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Hu Z; Medeiros LJ; Wang W; Chen Z; Tang G; Hodjat P; Yang S; Fang L; Li Y; Verstovsek S; Hu S
Mod Pathol; 2017 Jul; 30(7):940-951. PubMed ID: 28338652
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
17. Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2.
Kjeldsen E; Veigaard C; Aggerholm A; Hasle H
Gene; 2018 May; 656():86-94. PubMed ID: 29496554
[TBL] [Abstract][Full Text] [Related]
18. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24).
Lin P; Lennon PA; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2009 Sep; 193(2):119-22. PubMed ID: 19665075
[TBL] [Abstract][Full Text] [Related]
19. A t(3;8)(q26.2;q24) involving the EVI1 (MECOM) Gene.
Liu K; Tirado CA
J Assoc Genet Technol; 2018; 44(3):92-99. PubMed ID: 30208012
[TBL] [Abstract][Full Text] [Related]
20. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.
Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P
Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
